日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Psychometric hepatic encephalopathy score (PHES) - when, how, why, and why not: a guide for the unfamiliar

心理测量肝性脑病评分(PHES)——何时、如何、为何以及为何不适用:新手指南

Mumdzhiev, Nikola; Tenev, Rumen V; Radicheva, Mariana P

Minimal hepatic encephalopathy: Characteristics and comparison of the main diagnostic modalities

轻微肝性脑病:特征及主要诊断方法的比较

Mumdzhiev, Nikola; Tenev, Rumen V; Radicheva, Mariana P

Cost-Effectiveness in Alternative Treatment Options for Pancreatic Pseudocysts

胰腺假性囊肿替代治疗方案的成本效益分析

Boyanov, Nikola; Milinich, Nikol; Shtereva, Katina; Madzharova, Katerina; Tufkova, Stoilka; Penkova-Radicheva, Mariana; Radicheva, Daniela; Shopov, Neno

Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes

因蛋白水解引起的 VTCN1 (B7-H4) 表达受损而导致胰岛外周保护功能丧失,与自身免疫性糖尿病的发展有关

Ilian A Radichev, Lilia V Maneva-Radicheva, Christina Amatya, Maryam Salehi, Camille Parker, Jacob Ellefson, Paul Burn, Alexei Y Savinov

Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development

Nardilysin 依赖的细胞相关 VTCN1 (B7-H4) 蛋白水解标志着 1 型糖尿病的发展

Ilian A Radichev, Lilia V Maneva-Radicheva, Christina Amatya, Camille Parker, Jacob Ellefson, Clive Wasserfall, Mark Atkinson, Paul Burn, Alexei Y Savinov

Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1

重组人组织激肽释放酶-1 治疗可抑制自身免疫性糖尿病

Lilia Maneva-Radicheva, Christina Amatya, Camille Parker, Jacob Ellefson, Ilian Radichev, Arvind Raghavan, Matthew L Charles, Mark S Williams, Mark S Robbins, Alexei Y Savinov